• Home
  • Improved multiparametric MRI discrimination between low-risk prostate cancer and benign tissues in a small cohort of 5α-reductase inhibitor treated individuals as compared with an untreated cohort.

Improved multiparametric MRI discrimination between low-risk prostate cancer and benign tissues in a small cohort of 5α-reductase inhibitor treated individuals as compared with an untreated cohort.

Author List
Starobinets O, Kurhanewicz J, Noworolski SM
Publication
NMR in biomedicine
Publication ID (Profile URL)
https://researcherprofiles.org/profile/1208579
Publication Year
2017
PubMed ID
28164396
Publication Title
Starobinets O, Kurhanewicz J, Noworolski SM. Improved multiparametric MRI discrimination between low-risk prostate cancer and benign tissues in a small cohort of 5α-reductase inhibitor treated individuals as compared with an untreated cohort. NMR Biomed. 2017 May; 30(5).